Emesis induced by low or minimal emetic risk chemotherapy.
about
Palonosetron exhibits higher total control rate compared to first-generation serotonin antagonists and improves appetite in delayed-phase chemotherapy-induced nausea and vomiting.2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.A prospective, observational, multicenter study on risk factors and prophylaxis for low emetic risk chemotherapy-induced nausea and vomiting.Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: a prospective, longitudinal, observational study.
P2860
Emesis induced by low or minimal emetic risk chemotherapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Emesis induced by low or minimal emetic risk chemotherapy.
@ast
Emesis induced by low or minimal emetic risk chemotherapy.
@en
type
label
Emesis induced by low or minimal emetic risk chemotherapy.
@ast
Emesis induced by low or minimal emetic risk chemotherapy.
@en
prefLabel
Emesis induced by low or minimal emetic risk chemotherapy.
@ast
Emesis induced by low or minimal emetic risk chemotherapy.
@en
P2093
P1476
Emesis induced by low or minimal emetic risk chemotherapy.
@en
P2093
Albano Del Favero
David Osoba
Enzo Ballatori
Maurizio Tonato
Rebecca A Clark-Snow
Sussanne Borjeson
P2888
P304
P356
10.1007/S00520-004-0703-5
P577
2004-11-18T00:00:00Z